NCT06420024

Brief Summary

Hearing voices (often referred to as "auditory hallucinations") is a common experience amongst the older adult population (those 65+ years of age) and can be associated with increased psychological distress. Acceptance and Commitment Therapy (ACT) is a psychological therapy that aims to reduce distress of hearing voices by altering the relationship someone has with voices, and has been shown to improve distress levels for working age adults who hear voices. ACT also appears to be a suitable intervention for older adults distressed by hearing voices, however, there is currently no research that has examined this. Therefore, research is now needed to evaluate whether ACT can support older adults who experience distress from hearing voices. This study will use a case study based research method, known as a Hermeneutic Single-Case Efficacy Design (HSCED) series. This method will involve 3 participants who will receive ACT for hearing voices. This will be delivered across approximately twelve 90-minute sessions. Participants will be asked to complete measures that assess areas such as distress levels and quality of life, which will be completed before, during and after therapy. A detailed report of each participant's level of progress will then be generated and evaluated by expert judges. This will determine whether progress has occurred as a direct result of the therapy, or due to other reasons, and allow conclusions to be drawn about the use of ACT for older adults distressed by hearing voices. Participants will be recruited from either Local Mental Health Teams at Nottinghamshire NHS Foundation Trust, or from the Hearing Voices Group in Beeston (Nottingham). Participants will be required to be age 65+ years and currently experience hearing voices that cause them distress. This study will be funded by the NHS and is estimated to last approximately 12-months with 5-months of participant involvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2023

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 23, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

August 2, 2023

Completed
10 months until next milestone

First Posted

Study publicly available on registry

May 17, 2024

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2024

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2023

Enrollment Period

11 months

First QC Date

March 23, 2023

Last Update Submit

August 7, 2024

Conditions

Outcome Measures

Primary Outcomes (6)

  • Voices Acceptance and Action Scale-9 (Brockman et al., 2015)

    Acceptance-based attitudes and actions in relation to voices

    Approx. 0 weeks (baseline), 6 weeks (mid-therapy), 12-14 weeks (post therapy), 16-18 weeks (4-6 week follow-up) following enrolment to the study.

  • Beliefs about voices questionnaire-revised (Chadwick et al., 2000)

    Beliefs, emotions, and behaviours relating to auditory hallucinations.

    Approx. 0 weeks (baseline), 6 weeks (mid-therapy), 12-14 weeks (post therapy), 16-18 weeks (4-6 week follow-up) following enrolment to the study.

  • Depression, Anxiety and Stress Scales-21 (Lovibond & Lovibond, 1995)

    Depression, Anxiety and Stress

    Approx. 0 weeks (baseline), 6 weeks (mid-therapy), 12-14 weeks (post therapy), 16-18 weeks (4-6 week follow-up) following enrolment to the study.

  • Comprehensive assessment of Acceptance and Commitment Therapy processes, short-form (Morris et al., 2019)

    Psychological flexibility

    Approx. 0 weeks (baseline), 6 weeks (mid-therapy), 12-14 weeks (post therapy), 16-18 weeks (4-6 week follow-up) following enrolment to the study.

  • Older People's Quality of Life questionnaire, brief version (Bowling et al., 2013)

    Quality of Life

    Approx. 0 weeks (baseline), 6 weeks (mid-therapy), 12-14 weeks (post therapy), 16-18 weeks (4-6 week follow-up) following enrolment to the study.

  • The Psychotic Symptom Rating Scales (Haddock et al., 1999) - Auditory Hallucination Sub-Scale

    Symptom severity of auditory hallucinations

    Approx. 0 weeks, 6 weeks, 12-14 weeks, 16-18 weeks following enrolment to the study.

Secondary Outcomes (1)

  • Simplified Personal Questionnaire (Elliott et al., 1999)

    Weekly during the intervention (i.e., once per week during the intervention phase - this is anticipated to occur within the first 12-14 weeks of the participant's involvement with the study)

Study Arms (1)

Intervention

EXPERIMENTAL

Participant will receive ACT intervention

Behavioral: Acceptance and Commitment Therapy

Interventions

See: https://link.springer.com/chapter/10.1007/0-306-48581-8\_1

Intervention

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Currently experiences HV
  • + years of age
  • Moderate levels of distress. This will be measured using recommended "Moderate" severity level cut-off scores on the Depression, Anxiety and Stress Scales-21 (Lovibond \& Lovibond, 1995) following the completion of Informed Consent Forms.
  • Having capacity to provide informed consent (in accordance with the Mental Capacity Act)
  • Willingness to engage in the intervention

You may not qualify if:

  • Diagnosis of cognitive impairment or dementia (based on self-report), as this indicates a degree of cognitive impairment that would be difficult to accommodate for.
  • Current engagement with another psychological therapy
  • Unable to independently communicate in English without an interpreter (based on researcher's discretion at recruitment).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Derbyshire Healthcare NHS Foundation Trust

Derby, Derbyshire, DE22 3LZ, United Kingdom

Location

Nottinghamshire Healthcare NHS Foundation Trust

Nottingham, Nottinghamshire, NG3 6AA, United Kingdom

Location

MeSH Terms

Interventions

Acceptance and Commitment Therapy

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Danielle De Boos, DClinPsy

    University of Nottingham

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Hermeneutic Single Case Efficacy Design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 23, 2023

First Posted

May 17, 2024

Study Start

August 2, 2023

Primary Completion

June 20, 2024

Study Completion

June 20, 2024

Last Updated

August 9, 2024

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations